A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Trilostane
Acefylline
The risk or severity of adverse effects can be increased when Acefylline is combined with Indacaterol.
Trilostane
Proxyphylline
The risk or severity of adverse effects can be increased when Proxyphylline is combined with Indacaterol.
Trilostane
Bamifylline
The risk or severity of adverse effects can be increased when Bamifylline is combined with Indacaterol.
Trilostane
Theodrenaline
The risk or severity of adverse effects can be increased when Theodrenaline is combined with Indacaterol.
Trilostane
Cafedrine
The risk or severity of adverse effects can be increased when Cafedrine is combined with Indacaterol.
Trilostane
Lobucavir
The risk or severity of adverse effects can be increased when Lobucavir is combined with Indacaterol.
Trilostane
Lisofylline
The risk or severity of adverse effects can be increased when Lisofylline is combined with Indacaterol.
Trilostane
6-O-benzylguanine
The risk or severity of adverse effects can be increased when 6-O-benzylguanine is combined with Indacaterol.
Trilostane
Uric acid
The risk or severity of adverse effects can be increased when Uric acid is combined with Indacaterol.
Trilostane
3-isobutyl-1-methyl-7H-xanthine
The risk or severity of adverse effects can be increased when 3-isobutyl-1-methyl-7H-xanthine is combined with Indacaterol.
Trilostane
Valomaciclovir
The risk or severity of adverse effects can be increased when Valomaciclovir is combined with Indacaterol.
Trilostane
Propentofylline
The risk or severity of adverse effects can be increased when Propentofylline is combined with Indacaterol.
Trilostane
9-Deazaguanine
The risk or severity of adverse effects can be increased when 9-Deazaguanine is combined with Indacaterol.
Trilostane
Hypoxanthine
The risk or severity of adverse effects can be increased when Hypoxanthine is combined with Indacaterol.
Trilostane
Peldesine
The risk or severity of adverse effects can be increased when Peldesine is combined with Indacaterol.
Trilostane
9-Methylguanine
The risk or severity of adverse effects can be increased when 9-Methylguanine is combined with Indacaterol.
Trilostane
Guanine
The risk or severity of adverse effects can be increased when Guanine is combined with Indacaterol.
Trilostane
7-Deazaguanine
The risk or severity of adverse effects can be increased when 7-Deazaguanine is combined with Indacaterol.
Trilostane
Xanthine
The risk or severity of adverse effects can be increased when Xanthine is combined with Indacaterol.
Trilostane
7,9-Dimethylguanine
The risk or severity of adverse effects can be increased when 7,9-Dimethylguanine is combined with Indacaterol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3